Ishii Yoshiyuki 石井良幸

… Alternative Names

ISHII YOSHIYUKI 石井良幸

ISHII Yoshiyuki 石井良幸

石井良幸イシイヨシユキ

Less

Researcher Number	30255468
Other IDs	https://orcid.org/0000-0001-6696-4927
Affiliation (Current)	2025: 北里大学, 北里研究所病院, 教授
Affiliation (based on the past Project Information) *help	2011 – 2013: 慶應義塾大学, 医学部, 講師 2004 – 2005: 慶應義塾大学, 医学部, 助手 1996: 慶應義塾大学, 医学部, 助手
Review Section/Research Field	Principal Investigator Digestive surgery / General surgery Except Principal Investigator Digestive surgery
Keywords	Principal Investigator seisitivity / heat shock protein 27 / sensitivity / chemotherapy / colorectal cancer / Drug sensitivity / Biomarker / Colorectal cancer / Heat shock protein 27 / ADCC / 免疫療法 / 大腸癌 / モノクローナル抗体 … More Except Principal Investigator … More paclitaxel / epidermal growth factor receptor antibody / missile therapy / nanoparticle / oxaliplatin / CPT-11 / 大腸癌 / 抗EGFR抗体 / ミサイル療法 / ナノカプセル Less

Development of new therapy targeting HSP27 in colorectal cancerPrincipal Investigator
- Principal Investigator
  
  ISHII YOSHIYUKI
- Project Period (FY)
  2011 – 2013
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Digestive surgery
- Research Institution
  Keio University
The development of a new drug delivery system using nanoparticles including paclitaxel, conjugated with anti-epidermal growth factor receptor (EGFR) monoclonal antibody.
- Principal Investigator
  
  HASEGAWA Hirotoshi
- Project Period (FY)
  2004 – 2005
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Digestive surgery
- Research Institution
  Keio University
モノクローナル抗体(NCC-ST-421)を用いた新しい腫瘍特異的免疫療法の開発Principal Investigator
- Principal Investigator
  
  石井良幸
- Project Period (FY)
  1996
- Research Category
  
  Grant-in-Aid for Encouragement of Young Scientists (A)
- Research Field
  
  General surgery
- Research Institution
  Keio University

All 2014 2013 2012 2011 Other

All Journal Article Presentation Other

[Journal Article] Inhibition of heat shock protein 27 phosphorylation promotes sensitivity to 5-fluorouracil in colorectal cancer cells2014
- Author(s)
  Matsunaga A, Ishii Y, Tsuruta M, Okabayashi K, Hasegawa H, Kitagawa Y.
- Journal Title
  
  Oncology Letters
  
  Volume: (in press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591970
[Presentation] 大腸癌に対する分子標的治療薬(抗EGFR抗体薬)の効果におけるHeat Shock Protein 27の役割2013
- Author(s)
  石田隆，石井良幸，長谷川博俊，遠藤高志，岡林剛史，森谷弘乃介，茂田浩平，瀬尾雄樹，星野剛，菊池弘人，清島亮，高橋秀奈，松井信平，山田暢，北川雄光
- Organizer
  第68回日本消化器外科学会総会
- Place of Presentation
  宮崎
- Data Source
  KAKENHI-PROJECT-23591970
[Presentation] 大腸癌に対する分子標的治療薬(抗EGFR抗体薬)の効果におけるHeat Shock Protein 27の役割2013
- Author(s)
  石田隆,石井良幸,長谷川博俊,遠藤高志,岡林剛史,瀬尾雄樹,菊池弘人,清島亮,北川雄光
- Organizer
  第68回の本消化器外科学会総会
- Place of Presentation
  宮崎
- Year and Date
  2013-07-17
- Data Source
  KAKENHI-PROJECT-23591970
[Presentation] 大腸癌におけるバイオマーカーおよび治療標的としてのHeat Shock Protein 272012
- Author(s)
  石井良幸,落合大樹,松永篤志,石田隆,遠藤高志,長谷川博俊,北川雄光
- Organizer
  第67回日本消化器外科学会総会
- Place of Presentation
  富山
- Year and Date
  2012-07-20
- Data Source
  KAKENHI-PROJECT-23591970
[Presentation] 大腸癌における5-fluorouracil感受性の規定因子としてのHeat shock protein 27について, Heat shock protein 27 as a regulator of 5-fluorouracil sensitivity in colorectal cancer cells2011
- Author(s)
  松永篤志,石井良幸,長谷川博俊,遠藤高志,落合大樹,星野大樹,星野好則,茂田浩平,瀬尾雄樹,星野剛,北川雄光
- Organizer
  第70回日本癌学会学術総会
- Place of Presentation
  名古屋
- Year and Date
  2011-10-05
- Data Source
  KAKENHI-PROJECT-23591970
[Presentation] 大腸癌における5-fluorouracil感受性の規定因子としてのheat shock protein 27について2011
- Author(s)
  松永篤志、石井良幸、長谷川博俊、他
- Organizer
  第70回日本癌学会学術総会
- Place of Presentation
  愛知芸術文化センター（愛知県）
- Data Source
  KAKENHI-PROJECT-23591970
[]

1. HASEGAWA Hirotoshi (00218455)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

Ishii Yoshiyuki 石井 良幸

ISHII YOSHIYUKI 石井 良幸

ISHII Yoshiyuki 石井 良幸

石井 良幸 イシイ ヨシユキ

Research Projects

Research Products

Co-Researchers

Development of new therapy targeting HSP27 in colorectal cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

The development of a new drug delivery system using nanoparticles including paclitaxel, conjugated with anti-epidermal growth factor receptor (EGFR) monoclonal antibody.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

モノクローナル抗体(NCC-ST-421)を用いた新しい腫瘍特異的免疫療法の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Inhibition of heat shock protein 27 phosphorylation promotes sensitivity to 5-fluorouracil in colorectal cancer cells2014

Author(s)

Journal Title

Data Source

[Presentation] 大腸癌に対する分子標的治療薬(抗EGFR抗体薬)の効果におけるHeat Shock Protein 27の役割2013

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] 大腸癌に対する分子標的治療薬(抗EGFR抗体薬)の効果におけるHeat Shock Protein 27の役割2013

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] 大腸癌におけるバイオマーカーおよび治療標的としてのHeat Shock Protein 272012

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] 大腸癌における5-fluorouracil感受性の規定因子としてのHeat shock protein 27について, Heat shock protein 27 as a regulator of 5-fluorouracil sensitivity in colorectal cancer cells2011

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] 大腸癌における5-fluorouracil感受性の規定因子としてのheat shock protein 27について2011

Author(s)

Organizer

Place of Presentation

Data Source

[]

Ishii Yoshiyuki 石井良幸

ISHII YOSHIYUKI 石井良幸

ISHII Yoshiyuki 石井良幸

石井良幸イシイヨシユキ